| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Administration of low-dose combination anti-CTLA4, anti-CD137, and anti-OX40 into murine tumor or proximal to the tumor draining lymph node induces systemic tumor regression
|
Hebb, Jonathan P. O.
|
|
2017
|
67 |
1 |
p. 47-60
|
article
|
| 2 |
Bile duct obstruction in a patient treated with nivolumab as second-line chemotherapy for advanced non-small-cell lung cancer: a case report
|
Kashima, Jumpei
|
|
2017
|
67 |
1 |
p. 61-65
|
article
|
| 3 |
Clinical grade manufacturing of genetically modified, CAR-expressing NK-92 cells for the treatment of ErbB2-positive malignancies
|
Nowakowska, Paulina
|
|
2017
|
67 |
1 |
p. 25-38
|
article
|
| 4 |
Daunorubicin conjugated with alpha-fetoprotein selectively eliminates myeloid-derived suppressor cells (MDSCs) and inhibits experimental tumor growth
|
Belyaev, Nikolai N.
|
|
2017
|
67 |
1 |
p. 101-111
|
article
|
| 5 |
HLA class I expression predicts prognosis and therapeutic benefits from tyrosine kinase inhibitors in metastatic renal-cell carcinoma patients
|
Wang, Jiajun
|
|
2017
|
67 |
1 |
p. 79-87
|
article
|
| 6 |
Immunological classification of renal cell carcinoma patients based on phenotypic analysis of immune check-point molecules
|
Kawashima, Atsunari
|
|
2017
|
67 |
1 |
p. 113-125
|
article
|
| 7 |
Ipilimumab and early signs of pulmonary toxicity in patients with metastastic melanoma: a prospective observational study
|
Franzen, Daniel
|
|
2017
|
67 |
1 |
p. 127-134
|
article
|
| 8 |
Monitoring the response of urothelial precancerous lesions to Bacillus Calmette-Guerin at the proteome level in an in vivo rat model
|
Teke, Kerem
|
|
2017
|
67 |
1 |
p. 67-77
|
article
|
| 9 |
2nd Symposium on Advances in Cancer Immunology and Immunotherapy, December 15–17, 2016, Athens, Greece
|
Samara, Pinelopi
|
|
2017
|
67 |
1 |
p. 153-159
|
article
|
| 10 |
Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer
|
Fucikova, Jitka
|
|
2017
|
67 |
1 |
p. 89-100
|
article
|
| 11 |
Quantification of altered tissue turnover in a liquid biopsy: a proposed precision medicine tool to assess chronic inflammation and desmoplasia associated with a pro-cancerous niche and response to immuno-therapeutic anti-tumor modalities
|
Willumsen, Nicholas
|
|
2017
|
67 |
1 |
p. 1-12
|
article
|
| 12 |
Safety of shortened infusion times for combined ipilimumab and nivolumab
|
Gassenmaier, Maximilian
|
|
2017
|
67 |
1 |
p. 135-140
|
article
|
| 13 |
The STAT3 inhibitor pyrimethamine displays anti-cancer and immune stimulatory effects in murine models of breast cancer
|
Khan, Mohammad W.
|
|
2017
|
67 |
1 |
p. 13-23
|
article
|
| 14 |
Tumor-infiltrating immune cells as potential biomarkers predicting response to treatment and survival in patients with metastatic melanoma receiving ipilimumab therapy
|
Balatoni, Tímea
|
|
2017
|
67 |
1 |
p. 141-151
|
article
|
| 15 |
Tumor infiltrating lymphocytes in lymph node metastases of stage III melanoma correspond to response and survival in nine patients treated with ipilimumab at the time of stage IV disease
|
Diem, Stefan
|
|
2017
|
67 |
1 |
p. 39-45
|
article
|
Journal description